Dr Chih-Liang Chin | Director and Site Lead, Imaging
MSD/ Translation Medicine Research Centre

Chih-Liang Chin, Ph.D. is Director and Site Lead Imaging, Translational Medicine Research Centre at Merck & Sharp Dohme, Singapore. In this role, Chih-Liang provides leadership and coordination for the development of translational imaging biomarker in nonhuman primate across various disease franchises. His team also supports the early stage experimental medicine imaging study in human. Dr. Chin joined Merck in 2011 after seven years at Abbott Laboratories as Senior Scientist and Head, Neuroscience / Immunoscience Imaging, Translational Sciences, Global Pharmaceutical Research & Development, where his team focused on developing biomarkers in rodent models of neurological and psychiatric diseases using multi-modality imaging. Dr. Chin has received his Ph.D. in Bioengineering from the University of Pennsylvania. He was also Research Fellow in at Brigham & Women's Hospital, Harvard Medical School. Throughout his career, he has actively published and served as Reviewer for several scientific imaging journals. Dr. Chin is currently a member of International Society of Magnetic Resonance in Medicine (ISMRM) and American Society for Pharmacology and Experimental Therapeutics (ASPET).